Janet Worrell

About Janet Worrell

Janet is Head of Regulatory at Jenson R+ Ltd and joined the company in April 2019 after running her own consultancy business, consult2deliver limited, based in BioCity Nottingham.

Medicines Management in Sport 03 Nov 2020 11am

2021-01-12T13:44:51+00:00October 13th, 2020|

Medicines Management in Professional Sport One aspect of taking the plunge and being a freelance regulatory consultant, is the opportunity to explore new ideas and concepts. Especially when you decide to decide to run 3 networking events a year and need to embrace and use all of your networking skills repeatedly. I am pleased [...]

CBD – the dynamic ingredient. Free to attend Webinar Thursday 29 October

2021-01-12T13:45:28+00:00September 21st, 2020|

CBD and the latest developments. Our last Special interest Group (SIG) of the year is all about Cannabidiol (CBD). Its been an explosive new kid on the block. Within the space of a couple of years, CBD ingestibles have transitioned from a lightly regulated consumer product to potentially being classified as a narcotic and [...]

Two Regulatory Roles

2021-01-12T13:45:44+00:00August 10th, 2020|

Join us JensonR+ are a leading consultancy providing a wide range of regulatory support to life science businesses with a focus on UK and Republic of Ireland markets. Due to continued growth, we are looking to recruit life science graduates to join our specialist teams in our Barnstaple, Devon and Nottingham offices. This opportunity [...]

Two Roles in Regulatory Affairs – join our team

2021-01-12T13:46:05+00:00August 10th, 2020|

JensonR+ are a leading consultancy providing a wide range of regulatory support to life science businesses with a focus on UK and Republic of Ireland markets. Due to continued growth, we are looking to recruit life science graduates to join our specialist teams in our Barnstaple, Devon and Nottingham offices. This opportunity will allow you [...]

ABPI Consultation on the proposed 2021 ABPI Code of Practice for the Pharmaceutical Industry

2021-01-12T13:46:30+00:00July 16th, 2020|

The Association of British Pharmaceutical Industry (ABPI) and The Prescription Medicines Code of Practice Authority (PMCPA)* have launched a consultation for the proposed changes for the 2021 Code of Practice. The changes are designed to bring the ABPI Code up-to-date and reflect the recent updates made to the 2019 EFPIA Code.

Brexit Strategy Legal Presence Requirements in UK

2021-01-12T13:46:48+00:00July 2nd, 2020|

Legal presence requirements in UK The transition period was not extended at five minutes to midnight on 30 June 2020. In theory the UK and EU may negotiate an agreement which means that all the previously published MHRA requirements listed for a “no deal” Brexit may not be needed at the end of the [...]